1990-2016年全球阿尔茨海默病及其他痴呆症负担的系统分析
该研究基于GBD 2016,分析1990-2016年195个国家和地区的痴呆症患病、死亡及疾病负担。
核心结论
- 全球痴呆症患者数1990至2016年翻倍以上,主要归因于人口老龄化和增长。
- 在预防或治愈突破之前,痴呆症对全球卫生系统构成日益严峻的挑战。
研究设计与样本
- GBD 2016系统分析,纳入1990-2016年195个国家和地区的生命登记、文献、调查及卫生服务数据。
- 采用标准化方法估计死亡、患病、YLLs、YLDs和DALYs,并分析四个可干预危险因素的归因份额。
关键数值与推荐
- 年龄标化患病率从1990年701例/10万(95%UI 602-815)升至2016年712例/10万(614-828)。
临床怎么用
- 临床医生应关注痴呆症可干预危险因素(高BMI、高血糖、吸烟、高糖饮料摄入)以降低疾病负担。
- 鉴于痴呆症患者数快速增长,需加强卫生系统应对和早期识别。
局限性
- 死因编码差异和病例确认方法异质性构成痴呆症负担估计的主要挑战。
- 未来分析应改进对上述偏倚的校正方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The number of individuals living with dementia is increasing, negatively affecting families, communities, and health-care systems around the world. A successful response to these challenges requires an accurate understanding of the dementia disease burden. We aimed to present the first detailed analysis of the global prevalence, mortality, and overall burden of dementia as captured by the Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2016, and highlight the most important messages for clinicians and neurologists. METHODS: GBD 2016 obtained data on dementia from vital registration systems, published scientific literature and surveys, and data from health-service encounters on deaths, excess mortality, prevalence, and incidence from 195 countries and territories from 1990 to 2016, through systematic review and additional data-seeking efforts. To correct for differences in cause of death coding across time and locations, we modelled mortality due to dementia using prevalence data and estimates of excess mortality derived from countries that were most likely to code deaths to dementia relative to prevalence. Data were analysed by standardised methods to estimate deaths, prevalence, years of life lost (YLLs), years of life lived with disability (YLDs), and disability-adjusted life-years (DALYs; computed as the sum of YLLs and YLDs), and the fractions of these metrics that were attributable to four risk factors that met GBD criteria for assessment (high body-mass index [BMI], high fasting plasma glucose, smoking, and a diet high in sugar-sweetened beverages). FINDINGS: In 2016, the global number of individuals who lived with dementia was 43·8 million (95% uncertainty interval [UI] 37·8-51·0), increased from 20.2 million (17·4-23·5) in 1990. This increase of 117% (95% UI 114-121) contrasted with a minor increase in age-standardised prevalence of 1·7% (1·0-2·4), from 701 cases (95% UI 602-815) per 100 000 population in 1990 to 712 cases (614-828) per 100 000 population in 2016. More women than men had dementia in 2016 (27·0 million, 95% UI 23·3-31·4, vs 16.8 million, 14.4-19.6), and dementia was the fifth leading cause of death globally, accounting for 2·4 million (95% UI 2·1-2·8) deaths. Overall, 28·8 million (95% UI 24·5-34·0) DALYs were attributed to dementia; 6·4 million (95% UI 3·4-10·5) of these could be attributed to the modifiable GBD risk factors of high BMI, high fasting plasma glucose, smoking, and a high intake of sugar-sweetened beverages. INTERPRETATION: The global number of people living with dementia more than doubled from 1990 to 2016, mainly due to increases in population ageing and growth. Although differences in coding for causes of death and the heterogeneity in case-ascertainment methods constitute major challenges to the estimation of the burden of dementia, future analyses should improve on the methods for the correction of these biases. Until breakthroughs are made in prevention or curative treatment, dementia will constitute an increasing challenge to health-care systems worldwide. FUNDING: Bill & Melinda Gates Foundation.
引用
- Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018. PMID: 30497964. doi:10.1016/S1474-4422(18)30403-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。